These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6704194)

  • 1. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies.
    Williams RC; Malone CC; Silvestris F
    Clin Immunol Immunopathol; 1996 Aug; 80(2):194-203. PubMed ID: 8764565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens.
    Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F
    Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM and IgG anti-F(ab')2 antibodies in rheumatoid arthritis and systemic lupus erythematosus.
    Heimer R; Wolfe LD; Abruzzo JL
    Arthritis Rheum; 1982 Nov; 25(11):1298-1306. PubMed ID: 6982718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
    Davey MP; Korngold L
    Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition of immune deposits present in glomeruli of NZB/W F1 mice.
    Sugisaki T; Takase S
    Clin Immunol Immunopathol; 1991 Dec; 61(3):296-308. PubMed ID: 1934620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring human antibodies to the F(ab')2 portion of IgG.
    Nasu H; Chia DS; Knutson DW; Barnett EV
    Clin Exp Immunol; 1980 Nov; 42(2):378-86. PubMed ID: 6970643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
    Jordan SC; Gautier E; Sakai R; Bahn L
    J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
    Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
    J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU; Fumia S
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of IgM antibodies to pooled human F(ab')2 fragments.
    Wolfe LD; Abruzzo JL; Heimer R
    Immunol Commun; 1984; 13(1):15-27. PubMed ID: 6203827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus.
    Silvestris F; Yancey WB; Malone C; Searles R; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 May; 59(2):256-70. PubMed ID: 2009644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IgM Antibody against IgG Antibody Binding to Antigen, So-Called Anti-Antibody, Reacts Mainly with F (ab')₂ Fragment Possessing Antibody Activity].
    Matsuura T; Imamura A; Ota T
    Rinsho Byori; 2017 Jan; 65(1):13-18. PubMed ID: 30695506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA; Taniguchi O; Barnett EV
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.